000 | 01277 a2200373 4500 | ||
---|---|---|---|
005 | 20250513110353.0 | ||
264 | 0 | _c19970429 | |
008 | 199704s 0 0 eng d | ||
022 | _a0301-0147 | ||
024 | 7 |
_a10.1159/000217293 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSandset, P M | |
245 | 0 | 0 |
_aTissue factor pathway inhibitor (TFPI)--an update. _h[electronic resource] |
260 |
_bHaemostasis _cOct 1996 |
||
300 |
_a154-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntithrombins _xpharmacology |
650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
650 | 0 | 4 |
_aFactor VIIa _xmetabolism |
650 | 0 | 4 | _aFactor Xa Inhibitors |
650 | 0 | 4 |
_aHemophilia A _xdrug therapy |
650 | 0 | 4 |
_aHeparin _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLipoproteins _xchemistry |
650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xtherapeutic use |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
773 | 0 |
_tHaemostasis _gvol. 26 Suppl 4 _gp. 154-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000217293 _zAvailable from publisher's website |
999 |
_c8970722 _d8970722 |